Eiger BioPharmaceuticals
Stock Forecast, Prediction & Price Target

	Passed			Analyst forecast
Metric	12/31/2021	12/31/2022	12/31/2023	12/31/2025	12/31/2026	12/31/2027
Revenue % change YoY	$12.14M N/A	$13.48M 11.05%	$15.77M 16.97%	Avg: $32.65M Low: $32.65M High: $32.65M avg. 107.02%	Avg: $34.35M Low: $34.35M High: $34.35M avg. 5.21%	Avg: $36.15M Low: $36.15M High: $36.15M avg. 5.22%
Net Income % change YoY	$-33.91M N/A	$-96.77M -185.33%	$-74.96M 22.53%	Avg: $-9.59M Low: $-5.31M High: $-5.31M avg. 87.20%	Avg: $-8.33M Low: $-4.42M High: $-4.42M avg. 13.08%	Avg: $-3.54M Low: $-3.54M High: $-3.54M avg. 57.51%
EBITDA % change YoY	$-30.29M N/A	$-92.62M -205.74%	$-68.74M 25.78%	Avg: $-6.53M Low: $-6.53M High: $-6.53M avg. 90.49%	Avg: $-6.87M Low: $-6.87M High: $-6.87M avg. -5.21%	Avg: $-7.23M Low: $-7.23M High: $-7.23M avg. -5.22%
EPS % change YoY	-$0.98 N/A	-$69.74 -7016.32%	-$50.78 27.18%	Avg: -$3.6 Low: -$3.6 High: -$3.6 avg. 92.91%	Avg: -$3 Low: -$3 High: -$3 avg. 16.66%	Avg: -$2.4 Low: -$2.4 High: -$2.4 avg. 20.00%
Operating Expenses % change YoY	$88.33M N/A	$104.38M 18.17%	$87.53M -16.14%	Avg: $50.44M Low: $50.44M High: $50.44M avg. -42.36%	Avg: $53.08M Low: $53.08M High: $53.08M avg. 5.21%	Avg: $55.85M Low: $55.85M High: $55.85M avg. 5.22%

FAQ

Wall Street analysts estimate the annual average earnings growth rate of 52.59% in 2025-2027.

We have gathered data from 1 analysts. Their low estimate is -5.31M, average is -9.59M and high is -5.31M.

Wall Street analysts forecast annual average revenue growth of 39.15% in 2025-2027.

We have gathered data from 1 analysts. Their low revenue estimate is $32.65M, average is $32.65M and high is $32.65M.

Wall Street analysts forecast annual average earnings growth of 43.19% in 2025-2027.

We have gathered data from 1 analysts. Their low earnings per share estimate is -$3.6, average is -$3.6 and high is $-3.6.